J. Tor

B. Clotet, G. Sirera, C. Tural, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients

K. Langohr, C. Rey-Joly, J. Tor, 2008, The open AIDS journal.

Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study

M. Torrens, J. Tor, D. Fuster, 2014, BMC Infectious Diseases.

Risk stratification for dissemination of tuberculosis in HIV-infected patients.

J. Tor, J. Llibre, J. Manterola, 1992, The Quarterly journal of medicine.

Prospective evaluation of latent tuberculosis with interferon-γ release assays in drug and alcohol abusers

I. Latorre, C. Rey-Joly, C. Prat, 2009, Epidemiology and Infection.

Unhealthy Alcohol Use, HIV Infection and Risk of Liver Fibrosis in Drug Users with Hepatitis C

A. Muñoz, S. Pérez-Hoyos, J. Tor, 2012, PloS one.

Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug users.

C. Tural, C. Rey-Joly, J. Tor, 2011, Current HIV research.

Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?

A. Muñoz, M. Farré, J. Tor, 2018, Drug and alcohol dependence.

Hyaluronic acid, transforming growth factor‐β1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co‐infection

C. Tural, I. Ojanguren, C. Rey-Joly, 2009, Journal of viral hepatitis.

Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries

B. Clotet, A. Ornelas, J. Tor, 2013, Scandinavian journal of infectious diseases.

Cannabis as Secondary Drug Is Not Associated With a Greater Risk of Death in Patients With Opiate, Cocaine, or Alcohol Dependence.

M. Farré, J. Tor, D. Fuster, 2017, Journal of addiction medicine.

Human Herpesvirus 6 in Spain: Seroprevalence in Blood Donors and Patients with Lymphoproliferative Disorders or HIV Infection

J. Prieto, V. Soriano, J. Tor, 1991, Vox sanguinis.

Systemic amyloidosis in cystic fibrosis.

J. Guàrdia, J. Tor, J. Vilaseca, 1981, American journal of diseases of children.

Baseline Factors associated with Haematological Toxicity that Leads to a Dosage Reduction of Pegylated Interferon-α2a and Ribavirin in HIV- and HCV-Coinfected Patients on HCV Antiviral Therapy

B. Clotet, G. Sirera, C. Tural, 2005, Antiviral Therapy.

Utility of echocardiography in AIDS.

B. Clotet, J. Romeu, G. Sirera, 1990, Chest.

Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs

D. Vlahov, A. Muñoz, J. Tor, 1997, International journal of STD & AIDS.

Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV.

B. Clotet, V. Soriano, V. Soriano, 1990, BMJ.

HIV Infection and Viral Hepatitis in Drug Abusers

M. Torrens, S. Pérez-Hoyos, J. Tor, 2013 .

Características de los pacientes adictos a la heroína admitidos en un programa de tratamiento con metadona

J. Tor, D. Fuster, R. Muga, 2014 .

Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.

Kristen M. Haut, O. Andreassen, M. Kaess, 2021, JAMA psychiatry.

Differences in Virological Response to Pegylated Interferon and Ribavirin between Hepatitis C Virus (Hcv)-Monoinfected and HCV–Hiv-Coinfected Patients

B. Clotet, G. Sirera, C. Tural, 2008, Antiviral therapy.

Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections

J. Tor, D. Fuster, R. Muga, 2016, World journal of hepatology.

BLASTOCYSTIS HOMINIS CHRONIC DIARRHOEA IN AIDS PATIENTS

J. Tor, J. Llibre, M. Foz, 1989, The Lancet.

T-lymphocyte subsets in hospitalized drug abusers: is there more than meets the eye?

J. Juncà, C. Rey-Joly, J. Tor, 1985, Archives of internal medicine.

Hospital outbreak of scabies stemming from two AIDS patients with Norwegian scabies

B. Clotet, J. Romeu, G. Sirera, 1990, The Lancet.

Asymptomatic esophageal candidiasis in the acquired-immunodeficiency-syndrome-related complex.

B. Clotet, J. Juncà, J. Tor, 1986, Annals of internal medicine.

Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co‐infected patients

G. Sirera, C. Tural, I. Ojanguren, 2003, Journal of viral hepatitis.

Michaelis‐Menten Kinetics of Stiripentol in Normal Humans

T. Moreland, H. Bléhaut, J. Tor, 1984, Epilepsia.

Mitochondrial Effects of a 24-Week Course of Pegylated-Interferon plus Ribavirin in Asymptomatic HCV/HIV Co-Infected Patients on Long-Term Treatment with Didanosine, Stavudine or Both

Ò. Miró, B. Clotet, C. Tural, 2004, Antiviral therapy.

Over-expression of CD8+ T-cell activation is associated with decreased CD4+ cells in patients seeking treatment of Alcohol Use Disorder.

A. Teniente, E. Martínez-Cáceres, J. Tor, 2017, Drug and alcohol dependence.

Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users

B. Clotet, G. Sirera, A. Muñoz, 2002, Epidemiology and Infection.

Risk factors for HIV-1 infection in parenteral drug users.

V. Soriano, C. Rey-Joly, J. Tor, 1990, AIDS.

The place of laparoscopy in women with ascites

J. Tor, J. Llibre, M. Foz, 1989, British journal of obstetrics and gynaecology.

Periodic meningitis and familial Mediterranean fever.

J. Guàrdia, J. Tor, J. Vilaseca, 1982, Archives of internal medicine.

Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.

B. Clotet, C. Tural, I. Ojanguren, 2012, AIDS research and human retroviruses.

Hepatitis C infection substantially reduces survival of alcohol-dependent patients

A. Muñoz, J. Tor, D. Fuster, 2018, Clinical epidemiology.

Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.

A. Muñoz, K. Langohr, C. Rey-Joly, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Synthetic Peptide Immunoassay for Diagnosis of HIV 2 Infection

V. Soriano, J. Tor, M. Foz, 1989, Vox sanguinis.

Major depressive disorder and attenuated negative symptoms in a child and adolescent sample with psychosis risk syndrome: the CAPRIS study

E. de la Serna, I. Baeza, G. Sugranyes, 2021, European Child & Adolescent Psychiatry.

Neuropsychological profile of children and adolescents with psychosis risk syndrome: the CAPRIS study

I. Baeza, G. Sugranyes, O. Puig, 2020, European Child & Adolescent Psychiatry.

Characterization of children and adolescents with psychosis risk syndrome: The Children and Adolescents Psychosis Risk Syndrome (CAPRIS) study

E. de la Serna, I. Baeza, G. Sugranyes, 2018, Early intervention in psychiatry.

Clinical high risk for psychosis in children and adolescents: a systematic review

I. Baeza, G. Sugranyes, O. Puig, 2018, European Child & Adolescent Psychiatry.

Recent stressful life events and stress sensitivity in children and adolescents at clinical risk for psychosis

I. Baeza, G. Sugranyes, O. Puig, 2021, Psychiatry Research.

Wide array of T-cell subpopulation alterations in patients with alcohol use disorders.

A. Teniente, E. Martínez-Cáceres, J. Tor, 2016, Drug and alcohol dependence.

Markers of Inflammation and Mortality in a Cohort of Patients With Alcohol Dependence

J. Tor, D. Fuster, R. Muga, 2015, Medicine.

A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations

C. Morrison, P. Vanhems, A. Kamali, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Folate deficiency in patients seeking treatment of alcohol use disorder.

J. Juncà, J. Tor, D. Fuster, 2017, Drug and alcohol dependence.

Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug use.

G. Sirera, A. Muñoz, C. Rey-Joly, 2000 .

Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy.

B. Clotet, G. Sirera, C. Tural, 2005, Antiviral therapy.

Natural history of parenteral drug addicts treated in a general hospital.

C. Rey-Joly, J. Tor, R. Muga, 1990, British journal of addiction.

Temporal trends in the survival of drug and alcohol abusers according to the primary drug of admission to treatment in Spain.

M. Torrens, F. Fonseca, S. Pérez-Hoyos, 2014, Drug and alcohol dependence.

E. De Clercq, B. Clotet, J. Leonard, 1996, AIDS.

Asymptomatic HIV

B. Clotet, J. Romeu, C. Tural, 1988, Neurology.

Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients

M. de Antonio, M. Domingo, J. Lupón, 2018, BMC Geriatrics.

Early Postdischarge STOP-HF-Clinic Reduces 30-day Readmissions in Old and Frail Patients With Heart Failure.

M. de Antonio, M. Domingo, J. Lupón, 2017, Revista espanola de cardiologia.

Alcohol Consumption during Pregnancy: Analysis of Two Direct Metabolites of Ethanol in Meconium

M. Farré, J. Tor, R. Muga, 2016, International journal of molecular sciences.

Epidemiology of HIV-2 infection in Spain

A. Heredia, V. Soriano, I. Hewlett, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA Study.

M. Farré, G. Rubio, M. Torrens, 2018, Adicciones.

Impact of medical comorbidity and risk of death in 680 patients with alcohol use disorders.

M. Torrens, C. Rey-Joly, J. Tor, 2013, Alcoholism, clinical and experimental research.

Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment.

J. Tor, D. Fuster, R. Muga, 2019, Alcoholism, clinical and experimental research.

Liver Ultrasound Abnormalities in Alcohol Use Disorder

J. Tor, D. Fuster, R. Muga, 2019, Essentials of Abdominal Ultrasound.

[Multifocal tubercular osteitis in a female patient infected with the human immunodeficiency virus].

V. Soriano, J. Tor, T. Gros, 1992, Revista clinica espanola.

Synthetic Peptide Immunoassay in Diagnosis of Primary HIV Infection

V. Soriano, J. Tor, R. Muga, 1990, Vox sanguinis.

[Comparative effectiveness of alpha-2 adrenergic agonists (clonidine-guanfacine) in the hospital detoxification of opiate addicts].

J. Tor, J. Altés, R. Muga, 1990, Medicina clinica.

Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment.

J. Tor, D. Fuster, R. Muga, 2020, Drug and alcohol dependence.

Changes in bloodstream infections in HIV-positive patients in a university hospital in Spain (1995-1997).

B. Clotet, J. Romeu, M. Giménez, 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Acceptability of HIV Vaccine - Efficacy Trials in Drug Users and Sexual Partners of HIV Infected Patients in Barcelona, Spain

B. Clotet, J. Romeu, J. Tor, 2011 .

HTLV-I in Spain

V. Soriano, J. Tor, B. Clotet, 1990, The Lancet.

HTLV‐I and HTLV‐II Infections in Spain

V. Soriano, M. Ollero, M. Leal, 1993, Vox sanguinis.

HIV-1, HIV-2 and HTLV-I infection in high-risk groups in Spain.

V. Soriano, J. Tor, R. Muga, 1989, AIDS.

[The human immunodeficiency virus type 2 (HIV-2)].

V. Soriano, J. Tor, R. Muga, 1990, Revista clinica espanola.

Non-Parenteral Transmission of Hepatitis C Virus

V. Soriano, J. Tor, J. Casabona, 1991, International Journal of STD and AIDS.

HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.

C. Rey-Joly, J. Tor, R. Muga, 1986, Archives of internal medicine.

Progression of liver fibrosis in HIV/hepatitis C virus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline

B. Clotet, C. Tural, I. Ojanguren, 2014, HIV medicine.

Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV‐Coinfected Patients in Clinical Practice

B. Clotet, C. Tural, N. Pérez-Álvarez, 2018, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[Bacteremia in outpatients: a 10-year period follow-up].

C. Prat, M. Giménez, J. Tor, 2007, Medicina clinica.

[Detection of bacteremia in patients discharged from an emergency unit: study of 61 cases].

M. Giménez, J. Tor, N. Sopena, 1998, Medicina clinica.

Impact of hepatitis C virus infection on the risk of death of alcohol‐dependent patients

J. Tor, D. Fuster, R. Muga, 2015, Journal of viral hepatitis.

HIV antigenaemia and prognosis.

B. Clotet, V. Soriano, J. Tor, 1987, British medical journal.

Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy.

B. Clotet, G. Sirera, C. Tural, 2004, AIDS research and human retroviruses.

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus

Anne M Johnson, C. Morrison, P. Vanhems, 2017, The Journal of antimicrobial chemotherapy.